Navigation Links
NantKwest Shareholder (NK) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of NantKwest, Inc.; Encourages Investors to Contact the Firm
Date:3/14/2016

SAN DIEGO, March 14, 2016 /PRNewswire/ -- Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by NantKwest, Inc. (NASDAQ: NK) and certain of its officers. NantKwest, a biotechnology company, develops immunotherapeutic agents for various clinical conditions.

Specifically, Johnson & Weaver's investigation seeks to determine whether certain statements regarding the Company's business and prospects were false and misleading when made.

On July 28, 2015, NantKwest's stock traded as high as $38.48, the same day the Company sold 8.3 million shares of stock in its initial public stock offering (the "IPO"), raising $207.2 million in new capital.  However, since the IPO, NantKwest's stock has imploded, falling from its high of $38.48 on July 28, 2015 to close at $8.37 on March 14, 2016.

On March 11, 2016, NantKwest announced that its interim financial statements for the quarters ended June 30, 2015 and September 30, 2015 should no longer be relied upon due to the errors in the financial statements, mainly attributable to certain stock-based awards to NantKwest's Chief Executive Officer and Executive Chairman and build-to-suit lease accounting related to one of its research and development and Good Manufacturing Practices facilities. NantKwest management has announced that these errors were the result of a material weakness in its internal controls of financial reporting. NantKwest further acknowledged that "the material weakness, as disclosed in previous filings, is a result of inadequate staffing levels, resulting in insufficient time spent on review and approval of certain information used to prepare our financial statements and the maintenance of effective controls to adequately monitor and review significant transactions for financial statement completeness and accuracy. Management is continuing to assess the effect of the restatement on the Company's internal control over financial reporting and disclosure controls and procedures and expects to report its conclusions regarding these matters in the Company's Annual Report on Form 10-K for the year ended December 31, 2015".

If you are a NantKwest shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker (jimb@johnsonandweaver.com) at 619-814-4471. If you email, please include your phone number.

Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:

Johnson & Weaver, LLP
Jim Baker, 619-814-4471
jimb@johnsonandweaver.com

Logo - http://photos.prnewswire.com/prnh/20160211/332409LOGO

 


'/>"/>
SOURCE Johnson & Weaver, LLP
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. Spherix Releases Update Letter to Shareholders
2. Spherix Moves to Maintain NASDAQ Compliance as Shareholders Approve Reverse Split
3. Asterias Biotherapeutics Announces Intention to Distribute 3.15 Million Warrants to Purchase Common Shares of Asterias to Asterias Shareholders
4. Oxis Chairman And CEO Tells Shareholders Biotech Company Making Substantial Progress With Lead Cancer Drug, Drawing Closer To NASDAQ Listing
5. ProMIS Neurosciences Adopts Shareholder Rights Plan
6. Regen BioPharma President Harry Lander Provides Open Letter to Shareholders on Companys Progress and Developments
7. Lone Star Value Issues Statement To Fellow Enzo Shareholders
8. Selling Shareholder Prices Secondary Offering
9. Selling Shareholder Launches Proposed Secondary Offering
10. BrainStorm Hosting Conference Call to Update Shareholders on Important Developments
11. LabStyle Innovations Closes $2.3 Million Round of Investment From Existing Shareholders and Private Investors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... 24, 2017 Intralytix, Inc. announced that it ... a French family group. This investment marks the beginning ... and commercialize bacteriophage-based products, for various benefits in human ... As a global ... and markets innovative solutions for baking, food taste & ...
(Date:7/24/2017)... FL (PRWEB) , ... July ... ... Strategic Analyst, Kenny Soulstring, today announced that the stock market news outlet ... in risk assessment diagnostic testing that screens and identifies exposure, progression and ...
(Date:7/20/2017)... ... July 20, 2017 , ... Resoundant, Inc. is ... imaging centers around the U.S. that offer MR Elastography for liver fibrosis staging. ... needle biopsy for staging liver fibrosis assessment. , “MRE:connect was created in response ...
(Date:7/20/2017)... ... July 20, 2017 , ... Litmus Health ... announced its full advisory board. The board comprises leaders spanning business, technology, academia, ... PhD, former VP of Engineering, to Chief Technology Officer. Crooks will lead strategy ...
Breaking Biology Technology:
(Date:3/30/2017)... HONG KONG , March 30, 2017 ... developed a system for three-dimensional (3D) fingerprint identification by adopting ground ... technology into a new realm of speed and accuracy for use ... applications at an affordable cost. ... ...
(Date:3/27/2017)... 2017  Catholic Health Services (CHS) has been ... (HIMSS) Analytics for achieving Stage 6 on the ... In addition, CHS previously earned a place in ... electronic medical record (EMR). "HIMSS Analytics ... EMR usage in an outpatient setting.  This recognition ...
(Date:3/23/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Vehicle Anti-Theft System ... over the next decade to reach approximately $14.21 billion by 2025. ... forecasts for all the given segments on global as well as ...
Breaking Biology News(10 mins):